CA Patent
CA3022068A1 — Methods of treating circadian rhythm sleep disorders
Assigned to Eisai R&D Management Co Ltd · Expires 2017-11-16 · 9y expired
What this patent protects
Methods of treating irregular sleep-wake rhythm disorder in subjects and compositions for use in the same are disclosed.
USPTO Abstract
Methods of treating irregular sleep-wake rhythm disorder in subjects and compositions for use in the same are disclosed.
Drugs covered by this patent
- Dayvigo (LEMBOREXANT) · Eisai
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.